Janas-Kozik M - Search Results

1

Telepsychiatry and Virtual Reality an the Teatment of Patients with Intellectual and Developmental Disabilities.

Krysta K, Krzystanek M, Cubała WJ, Wiglusz MS, Jakuszkowiak-Wojten K, Gałuszko-Węgielnik M, Czarnowska-Cubała M, Szarmach J, Włodarczyk A, Janas-Kozik M. Krysta K, et al. Psychiatr Danub. 2017 Sep;29(Suppl 3):656-659. Psychiatr Danub. 2017. PMID: 28953847

2

Bright light treatment of depressive symptoms in patients with restrictive type of anorexia nervosa.

Janas-Kozik M, Krzystanek M, Stachowicz M, Krupka-Matuszczyk I, Janas A, Rybakowski JK. Janas-Kozik M, et al. J Affect Disord. 2011 May;130(3):462-5. doi: 10.1016/j.jad.2010.10.014. Epub 2010 Nov 13. J Affect Disord. 2011. PMID: 21075452 Clinical Trial.

3

Plasma levels of leptin and orexin A in the restrictive type of anorexia nervosa.

Janas-Kozik M, Stachowicz M, Krupka-Matuszczyk I, Szymszal J, Krysta K, Janas A, Rybakowski JK. Janas-Kozik M, et al. Regul Pept. 2011 Jun 7;168(1-3):5-9. doi: 10.1016/j.regpep.2011.02.005. Epub 2011 Feb 19. Regul Pept. 2011. PMID: 21338627

4

Bright light therapy in the treatment of childhood and adolescence depression, antepartum depression, and eating disorders.

Krysta K, Krzystanek M, Janas-Kozik M, Krupka-Matuszczyk I. Krysta K, et al. J Neural Transm (Vienna). 2012 Oct;119(10):1167-72. doi: 10.1007/s00702-012-0863-2. Epub 2012 Jul 19. J Neural Transm (Vienna). 2012. PMID: 22806006 Review.

5

Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis.

Krysta K, Krupka-Matuszczyk I, Janas-Kozik M, Stachowicz M, Szymszal J, Rybakowski JK. Krysta K, et al. Med Sci Monit. 2012 Sep;18(9):CR581-6. doi: 10.12659/msm.883355. Med Sci Monit. 2012. PMID: 22936195 Free PMC article.

6

Effects of olanzapine and paroxetine on phospholipase D activity in the rat brain.

Krzystanek M, Krzystanek E, Trzeciak HI, Małecki A, Krupka-Matuszczyk I, Janas-Kozik M, Rybakowski JK. Krzystanek M, et al. Pharmacol Rep. 2013;65(3):724-9. doi: 10.1016/s1734-1140(13)71051-x. Pharmacol Rep. 2013. PMID: 23950596 Free article.

7

Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning.

Krysta K, Krzystanek M, Janas-Kozik M, Klasik A, Krupka-Matuszczyk I. Krysta K, et al. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1(Suppl 1):S101-10. doi: 10.1007/s00702-014-1282-3. Epub 2014 Jul 31. J Neural Transm (Vienna). 2015. PMID: 25078256 Free PMC article. Review.

8

Analysis of facial expressions in patients with schziophrenia, in comparison with a healthy control - case study.

Dudek A, Wilczyński KM, Krysta K, Pęszor D, Martyniak E, Wojciechowska M, Krzystanek M, Wojciechowski K, Janas-Kozik M. Dudek A, et al. Psychiatr Danub. 2017 Sep;29(Suppl 3):584-589. Psychiatr Danub. 2017. PMID: 28953834

9

The Role of Hormones and Inflammatory Markers in Cognitive Functioning of Schizophrenic Patients.

Krysta K, Krzystanek M, Cubała WJ, Wiglusz MS, Jakuszkowiak-Wojten K, Gałuszko-Węgielnik M, Czarnowska-Cubała M, Szarmach J, Włodarczyk A, Janas-Kozik M. Krysta K, et al. Psychiatr Danub. 2017 Sep;29(Suppl 3):664-666. Psychiatr Danub. 2017. PMID: 28953849 Review.

10

Risk Factors for Noncompliance with Antipsychotic Medication in Long-Term Treated Chronic Schizophrenia Patients.

Krzystanek M, Krysta K, Janas-Kozik M, Martyniak E, Rybakowski J. Krzystanek M, et al. Psychiatr Danub. 2019 Sep;31(Suppl 3):543-548. Psychiatr Danub. 2019. PMID: 31488788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters